CareTrust Q3 Normalized FFO Up 20%, Raises 2026 Guidance Midpoints
CTRE is trading near its 52-week low of $34.55 (7.6% above the low).
Summary
CareTrust reported Q3 Normalized FFO of $129.2 million ($0.54 per share, up 20% year over year) and raised 2026 guidance to $2.08-$2.09 Normalized FFO per share, with leverage at just 1.4x ahead of a $1.2 billion acquisition pipeline.
Key Events · Earnings and Guidance · CTRE
-
Q3 Normalized FFO Up 20%
Normalized FFO was $129.2 million, or $0.54 per diluted share, versus $0.45 a year earlier; net income was $83.7 million ($0.35 per share) on revenue of $176.4 million, up from $132.4 million.
-
2026 Guidance Raised
Management lifted the low end of full-year guidance to $2.08-$2.09 Normalized FFO per share and $2.04-$2.05 Normalized FAD per share, with net income of $1.50-$1.51 per share on a 240 million diluted share count.
-
Leverage Well Below Target
Net debt to annualized normalized run rate EBITDA was 1.4x at quarter end, against a 4.0x-5.0x target range, with $1.6 billion available on the $2.0 billion revolver and $100 million of cash as of November 4, 2026.
-
Equity Already Issued in 2026
The quarter included $578.2 million of gross proceeds from settling the May 2026 forward equity offering and $280.5 million from ATM issuances; $599 million remains available under the ATM program.
Analysis · CTRE · Real Estate & Construction
The quarter was already out via the 10-Q and press coverage, but this 8-K carries the piece investors trade on: management raised the low end of 2026 guidance, now $2.08-$2.09 Normalized FFO per share and $2.04-$2.05 Normalized FAD per share. Against a $2.9 billion year-to-date investment pace at an 8.1% blended yield, leverage at 1.4x net debt to annualized run-rate EBITDA sits far below the 4.0x-5.0x target, leaving room to fund the remaining LNT homes and a $1.2 billion pipeline without new equity. The offset is dilution already taken: roughly 20.0 million ATM shares sold in 2026 at a $38.69 average plus a 14.4 million-share forward settlement, which is why per-share growth trails the absolute FFO increase.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 35.2% of the 2649 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTRE was trading at $37.18 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $8.8B. The 52-week trading range was $34.55 to $43.62. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.